Literature DB >> 20578381

[Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs].

Wei-Ru Xu1, Bao-Jin Hua, Wei Hou, Yan-Ju Bao.   

Abstract

OBJECTIVE: To seek the effective treatment for peripheral neuropathy induced by chemotherapeutic drugs.
METHODS: Sixty-four cases of peripheral neuropathy induced by Paclitaxel or Oxaliplatin were randomly divided into an acupuncture group and a medication group, 32 cases in each group. The acupuncture group was treated with therapeutic principle of dredging meridians and collaterals, tonifying qi and eliminating blood stasis, supplementing liver and kidney, nourishing blood and tendon. Hegu (LI 4), Taichong (LR 3), Zusanli (ST 36), Qihai (CV 6) and Quchi (LI 11) etc. were selected. The medication group was treated with intramuscular injection of Cobamamide. The neurotoxicity of two groups was compared with questionnaire of peripheral neuropathy induced by chemotherapeutic drugs before and after treatment.
RESULTS: The total effective rate for sensory nerve disorder of acupuncture group was 66.7% (20/30), which was superior to that of 40.0% (12/30) in medication group (P < 0.05).
CONCLUSION: Acupuncture is more effective than Cobamamide for treatment of peripheral neuropathy induced by chemotherapeutic drugs, especially for moderate and severe sensory nerve disorder induced by paclitaxel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578381

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  15 in total

1.  Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.

Authors:  Weidong Lu; Anita Giobbie-Hurder; Rachel A Freedman; Im Hee Shin; Nancy U Lin; Ann H Partridge; David S Rosenthal; Jennifer A Ligibel
Journal:  Oncologist       Date:  2019-10-14

2.  Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.

Authors:  Heather Greenlee; Katherine D Crew; Jillian Capodice; Danielle Awad; Donna Buono; Zaixing Shi; Anne Jeffres; Sharon Wyse; Wendy Whitman; Meghna S Trivedi; Kevin Kalinsky; Dawn L Hershman
Journal:  Breast Cancer Res Treat       Date:  2016-03-25       Impact factor: 4.872

Review 3.  Therapeutic strategies for cancer treatment related peripheral neuropathies.

Authors:  Deirdre R Pachman; James C Watson; Charles L Loprinzi
Journal:  Curr Treat Options Oncol       Date:  2014-12

4.  Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.

Authors:  Weidong Lu; Anita Giobbie-Hurder; Rachel A Freedman; Im Hee Shin; Nancy U Lin; Ann H Partridge; David S Rosenthal; Jennifer A Ligibel
Journal:  Oncologist       Date:  2019-10-14

Review 5.  Chemotherapy-Related Neurotoxicity.

Authors:  Sophie Taillibert; Emilie Le Rhun; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

Review 6.  Management options for established chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; James C Watson; Maryam B Lustberg; Nina D Wagner-Johnston; Alexandre Chan; Larry Broadfield; Yin Ting Cheung; Christopher Steer; Dawn J Storey; Kavita D Chandwani; Judith Paice; Pascal Jean-Pierre; Jeong Oh; Jayesh Kamath; Marie Fallon; Herwig Strik; Susanne Koeppen; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2014-05-31       Impact factor: 3.359

7.  A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathy.

Authors:  Giovanna Franconi; Luigi Manni; Sven Schröder; Paolo Marchetti; Nicola Robinson
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-24       Impact factor: 2.629

8.  Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture.

Authors:  M Rostock; K Jaroslawski; C Guethlin; R Ludtke; S Schröder; H H Bartsch
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-28       Impact factor: 2.629

9.  Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial.

Authors:  Joo-Hee Kim; Eun-Jung Kim; Byung-Kwan Seo; Sanghun Lee; Seunghoon Lee; So-Young Jung; Min-Hee Lee; Ae-Ran Kim; Hyo-Ju Park; Mi-Suk Shin; Sun-Mi Choi
Journal:  Trials       Date:  2013-08-14       Impact factor: 2.279

10.  Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study.

Authors:  M Kay Garcia; Lorenzo Cohen; Ying Guo; Yuhong Zhou; Bing You; Joseph Chiang; Robert Z Orlowski; Donna Weber; Jatin Shah; Raymond Alexanian; Sheeba Thomas; Jorge Romaguera; Liang Zhang; Maria Badillo; Yiming Chen; Qi Wei; Richard Lee; Kay Delasalle; Vivian Green; Michael Wang
Journal:  J Hematol Oncol       Date:  2014-05-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.